.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Federal Trade Commission
UBS
Cerilliant
Argus Health
Citi
Cipla
Deloitte
Fuji
Moodys

Generated: July 20, 2017

DrugPatentWatch Database Preview

Claims for Patent: 6,162,812

« Back to Dashboard

Claims for Patent: 6,162,812

Title: Pharmaceutical compositions containing HIV protease inhibitors and methods of their use
Abstract:HIV protease inhibitors, obtainable by chemical synthesis, inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds, as well as pharmaceutical compositions that contain these compounds and optically other anti-viral agents as active ingredients, are suitable for treating patients or hosts infected with the HIV virus, which is known to cause AIDS.
Inventor(s): Dressman; Bruce A. (Indianapolis, IN), Fritz; James E. (Greenwoode, IN), Hammond; Marlys (Pasadena, CA), Hornback; William J. (Indianapolis, IN), Kaldor; Stephen W. (Indianapolis, IN), Kalish; Vincent J. (San Diego, CA), Munroe; John E. (Indianapolis, IN), Reich; Siegfried Heinz (San Diego, CA), Tatlock; John H. (Poway, CA), Shepherd; Timothy A. (Indianapolis, IN), Rodriguez; Michael J. (Indianapolis, IN)
Assignee: Agouron Pharmaceuticals, Inc. (La Jolla, CA)
Application Number:09/283,152
Patent Claims: 1. A pharmaceutical composition comprising:

(a) an effective amount of a compound of the formula ##STR132## or a prodrug or pharmaceutically acceptable salt of said compound; and (b) a pharmaceutically acceptable carrier.

2. A pharmaceutical composition according to claim 1, wherein said compound, prodrug, or pharmaceutically acceptable salt (a) is a stereoisomer of the formula: ##STR133## or a prodrug or pharmaceutically acceptable salt of said steroisomer.

3. A pharmaceutical composition according to claim 2, wherein said compound, prodrug, or pharmaceutically acceptable salt (a) is said stereoisomer of the formula: ##STR134##

4. A pharmaceutical composition according to claim 2, wherein said compound, prodrug, or pharmaceutically acceptable salt (a) is a pharmaceutically acceptable salt of the formula:

5. A method of inhibiting HIV protease comprising administering to a host an effective amount of a compound of the formula: or a prodrug or pharmaceutically acceptable salt of said compound.

6. A method according to claim 5 wherein said compound, prodrug or pharmaceutically acceptable salt is a stereoisomer of the formula: ##STR135## or a prodrug or pharmaceutically acceptable salt of said stereoisomer.

7. A method according to claim 6 wherein said compound, prodrug or pharmaceutically acceptable salt is said stereoisomer of the formula: ##STR136##

8. A method according to claim 6 wherein said compound, prodrug or pharmaceutically acceptable salt is a pharmaceutically acceptable salt of the formula:
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Teva
Colorcon
Express Scripts
Harvard Business School
Accenture
Fuji
AstraZeneca
Covington
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot